The anti-tumor effect of the PTEN-mRNA loaded exosomes was evaluated in both immunodeficient and immune-competent PTEN-deficient glioma mouse models, and robust tumor inhibition and increased survival were obtained. This evidence concerns the gene PTEN and central nervous system cancer.